OTCPK:GNND.Y

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

GN Store Nord A/S develops, manufactures, and markets medical, professional, and consumer audio solutions in Denmark, rest of Europe, North America, and internationally. More Details


Snowflake Analysis

Reasonable growth potential with mediocre balance sheet.


Similar Companies

Share Price & News

How has GN Store Nord's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: GNND.Y has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

0%

GNND.Y

1.5%

US Medical Equipment

1.8%

US Market


1 Year Return

64.6%

GNND.Y

16.2%

US Medical Equipment

14.2%

US Market

Return vs Industry: GNND.Y exceeded the US Medical Equipment industry which returned 16.2% over the past year.

Return vs Market: GNND.Y exceeded the US Market which returned 14.2% over the past year.


Shareholder returns

GNND.YIndustryMarket
7 Day0%1.5%1.8%
30 Day0%1.2%0.04%
90 Day31.5%12.3%9.8%
1 Year65.1%64.6%17.2%16.2%16.7%14.2%
3 Year100.5%98.6%75.0%70.4%41.6%32.2%
5 Year294.1%286.8%144.8%126.4%90.9%69.5%

Price Volatility Vs. Market

How volatile is GN Store Nord's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is GN Store Nord undervalued compared to its fair value and its price relative to the market?

62.1x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: GNND.Y ($208.86) is trading above our estimate of fair value ($174.45)

Significantly Below Fair Value: GNND.Y is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: GNND.Y is poor value based on its PE Ratio (62.1x) compared to the US Medical Equipment industry average (48.4x).

PE vs Market: GNND.Y is poor value based on its PE Ratio (62.1x) compared to the US market (18.6x).


Price to Earnings Growth Ratio

PEG Ratio: GNND.Y is poor value based on its PEG Ratio (2.8x)


Price to Book Ratio

PB vs Industry: GNND.Y is overvalued based on its PB Ratio (13.8x) compared to the US Medical Equipment industry average (4x).


Next Steps

Future Growth

How is GN Store Nord forecast to perform in the next 1 to 3 years based on estimates from 16 analysts?

22.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: GNND.Y's forecast earnings growth (22% per year) is above the savings rate (2.2%).

Earnings vs Market: GNND.Y's earnings (22% per year) are forecast to grow slower than the US market (23.3% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: GNND.Y's revenue (10.5% per year) is forecast to grow faster than the US market (9.7% per year).

High Growth Revenue: GNND.Y's revenue (10.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: GNND.Y's Return on Equity is forecast to be high in 3 years time (31.3%)


Next Steps

Past Performance

How has GN Store Nord performed over the past 5 years?

10.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: GNND.Y has high quality earnings.

Growing Profit Margin: GNND.Y's current net profit margins (8.2%) are lower than last year (11.2%).


Past Earnings Growth Analysis

Earnings Trend: GNND.Y's earnings have grown by 10.8% per year over the past 5 years.

Accelerating Growth: GNND.Y's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: GNND.Y had negative earnings growth (-23%) over the past year, making it difficult to compare to the Medical Equipment industry average (-0.2%).


Return on Equity

High ROE: Whilst GNND.Y's Return on Equity (22.67%) is high, this metric is skewed due to their high level of debt.


Next Steps

Financial Health

How is GN Store Nord's financial position?


Financial Position Analysis

Short Term Liabilities: GNND.Y's short term assets (DKK5.2B) exceed its short term liabilities (DKK4.9B).

Long Term Liabilities: GNND.Y's short term assets (DKK5.2B) do not cover its long term liabilities (DKK6.3B).


Debt to Equity History and Analysis

Debt Level: GNND.Y's debt to equity ratio (134.7%) is considered high.

Reducing Debt: GNND.Y's debt to equity ratio has increased from 42.2% to 134.7% over the past 5 years.

Debt Coverage: GNND.Y's debt is well covered by operating cash flow (36.9%).

Interest Coverage: GNND.Y's interest payments on its debt are well covered by EBIT (168.8x coverage).


Balance Sheet


Next Steps

Dividend

What is GN Store Nord current dividend yield, its reliability and sustainability?

0.30%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: GNND.Y's dividend (0.3%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.66%).

High Dividend: GNND.Y's dividend (0.3%) is low compared to the top 25% of dividend payers in the US market (4.65%).


Stability and Growth of Payments

Stable Dividend: GNND.Y is not paying a notable dividend for the US market, therefore no need to check if payments are stable.

Growing Dividend: GNND.Y is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: GNND.Y is not paying a notable dividend for the US market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of GNND.Y's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

6.7yrs

Average board tenure


CEO

René Svendsen-Tune (65 yo)

no data

Tenure

kr.17,200,000

Compensation

Mr. René Svendsen-Tune serves as Chief Executive Officer at GN Store Nord A/S. Mr. Svendsen-Tune has been the Chief Executive Officer and President of GN Audio A/S since April 01, 2015 and serves as its Ch ...


CEO Compensation Analysis

Compensation vs Market: René's total compensation ($USD2.73M) is below average for companies of similar size in the US market ($USD11.31M).

Compensation vs Earnings: René's compensation has been consistent with company performance over the past year.


Board Members

NamePositionTenureCompensationOwnership
Per Wold-Olsen
Independent Chairman of the Board12.67yrsno data0.17%
DKK 17.2m
Wolfgang Reim
Independent Director12.25yrsno data0.040%
DKK 3.9m
Leo Larsen
Director13.67yrsno data0.00088%
DKK 86.8k
Morten Andersen
Director9yrsno data0.00035%
DKK 34.5k
Ronica Wang
Independent Director5.67yrsno data0.0038%
DKK 371.9k
Hélène Barnekow
Independent Director7.67yrsno data0.0078%
DKK 766.5k
Marcus Perathoner
Director2.42yrsno datano data
Jukka Pertola
Deputy Chairman of the Board of Directors0.50yrno datano data
Montserrat Pascual
Director0.50yrno datano data
Anette Weber
Director0.50yrno datano data

6.7yrs

Average Tenure

57.5yo

Average Age

Experienced Board: GNND.Y's board of directors are considered experienced (6.7 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

GN Store Nord A/S's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: GN Store Nord A/S
  • Ticker: GNND.Y
  • Exchange: OTCPK
  • Founded: 1869
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: kr.62.079b
  • Listing Market Cap: kr.9.865b
  • Shares outstanding: 128.77m
  • Website: https://www.gn.com

Number of Employees


Location

  • GN Store Nord A/S
  • Lautrupbjerg 7
  • Ballerup
  • Capital Region of Denmark
  • 2750
  • Denmark

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
GGND.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDJan 1992
GNNDB (Deutsche Boerse AG)YesOrdinary SharesDEEURJan 1992
GNCPSE (OMX Nordic Exchange Copenhagen)YesOrdinary SharesDKDKKJan 1992
0K9PLSE (London Stock Exchange)YesOrdinary SharesGBDKKJan 1992
GNCBATS-CHIXE (BATS 'Chi-X Europe')YesOrdinary SharesGBDKKJan 1992
GNND.YOTCPK (Pink Sheets LLC)ADRUSUSDSep 2012

Biography

GN Store Nord A/S develops, manufactures, and markets medical, professional, and consumer audio solutions in Denmark, rest of Europe, North America, and internationally. The company operates through GN Hea ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/18 05:45
End of Day Share Price2020/08/19 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.